跳至主要内容

How to ensure data quality and accuracy in non-clinical data exchange?

 


Ensuring data quality and accuracy in non-clinical data exchange requires multi-party collaboration and implementation of measures. It is very important to ensure the quality and accuracy of data in non-clinical data exchange. Here are some suggestions and methods:

1. Define clear data quality standards: Before data exchange begins, participants should clarify data quality standards, including requirements for data integrity, accuracy, consistency, authenticity, and legality. These standards should be consistent with the purposes of data exchange and the requirements for data use.

2. Data quality inspection: During the data exchange process, participants should conduct data quality inspection, including inspection of data integrity, accuracy, consistency and legality. These checks can be performed manually or using automated tools.

3. Data verification and verification: After receiving the data, the receiving party should verify and verify the data to ensure that the data meets quality standards. These verifications and verifications can include inspections of data format, content, logical relationships, etc., as well as comparisons with other data sources.

4. Use standardized data processing methods: Participants should adopt standardized data processing methods to ensure the consistency and accuracy of the data processing process. This includes standardized processes and methods for data cleaning, organization, and analysis.

5. Training and personnel quality improvement: Participants should provide training and personnel quality improvement plans to ensure that staff have the necessary data processing skills and knowledge and can understand and comply with data quality standards and data processing procedures.

6. Establish a data quality monitoring and improvement mechanism: Participants should establish a data quality monitoring and improvement mechanism, regularly assess the quality and accuracy of data, and discover and solve data quality problems. This includes mechanisms for establishing data quality assessment indicators, conducting regular data quality assessments, and tracking and resolving data quality issues.

7. Establish communication mechanisms and collaboration processes: Participants should establish effective communication mechanisms and collaboration processes to ensure timely communication and resolution of data quality and data processing issues between parties. This includes measures such as holding regular meetings, establishing communication channels, and developing collaboration processes.

In short, ensuring data quality and accuracy in non-clinical data exchange requires joint efforts and collaboration from all parties, including defining clear data quality standards, conducting data quality inspections, adopting standardized data processing methods, training and personnel quality improvement, Establish data quality monitoring and improvement mechanisms as well as establish communication mechanisms and collaboration processes.

评论

此博客中的热门博文

Custom Synthesis

Medicilon has synthesized over 10,000 individual compounds from gram to kilogram quantities, and many compounds are synthesized with more than ten synthetic steps. The overall synthesis success rate is over 95%. High quality products from mg to kg scale Reagents, intermediates, building blocks, and scaffolds Preparation of API or reference standards Development of synthetic routes for impurities and metabolites   On-site analytical support Product delivered with COA Medicilon offers integrated drug discovery services -- Chemistry, Biology & Preclinical Services

In Vitro Enzyme Activity Assay

  Kinases play extensive and important roles in signal transduction and co-ordination of complex functions. Currently, about 300 kinase inhibitors have been approved for marketing, among which receptor tyrosine kinase (RTK) inhibitors are the main ones. Medicilon provides high-quality kinase profile screening and has one-stop kinase research services from assay development, high-throughput screening to selectivity analysis. In addition, Medicilon provides many other enzyme activity screens. Wide Variety Provides 200+  in vitro  enzymatic detection methods; 100+ kinases, including CTK, RTK, AGC, CMGC and other kinase families as well as important common mutations Project Flexibility Various types of plates for screening, such as 96 and 384; Multiple flexible kinase profiles, including TK kinase family, CDK kinase family, etc., to meet different customer customization needs. Various Methods Fluorescence detection; Chemiluminescence detection; Absorbance detection LanthaScr...

Pharmacokinetics Services

Pharmacokinetics Services Our pharmacokinetics department offers the clients a broad spectrum of high quality of services in the areas of in vitro ADME, in vivo pharmacokinetics and bioanalysis services, ranging from small molecules to large molecules, such as protein and antibody. The animal species involved in our services are non-human primate, canine, mice, rat, rabbit and hamster. Meanwhile, non-human primate experimental platform and isotope platform for protein/antibody are certified by the Shanghai government. Preclinical Pharmacokinetics Method development and validation (GLP,Non-GLP) Bioanalysis Pharmacokinetics (Tumor bearing rodents, Bioavailability, Crossover studies, Cassette (N in 1) dosing and analysis, effects of gender on pharmacokinetics, BBB penetration ) Stability in vehicles and plasma Drug interaction studies In vitro metabolic stability CYP 450 inhibition Plasma protein binding studies Distribution studies Excretion studies Prediction an...